Mesalamine .375 g/1

Mesalamine .375 g/1 capsules are an extended-release medication used to manage inflammatory conditions. This oral treatment is designed to provide targeted relief and support gastrointestinal health.

Mesalamine .375 g/1 capsules are commonly used to manage symptoms associated with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. This medication helps to reduce inflammation in the digestive tract, promoting healing and alleviating discomfort. Mesalamine is often prescribed for long-term maintenance to prevent flare-ups and maintain remission.

Mesalamine .375 g/1 capsules are designed to release the active ingredient gradually, ensuring sustained relief. Common effects may include reduced inflammation, improved bowel function, and relief from symptoms such as abdominal pain and diarrhea. Some users may experience mild side effects, which typically subside as the body adjusts to the medication.

Mesalamine .375 g/1 capsules should be taken as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with known allergies to mesalamine or related compounds should avoid this medication. Always consult a healthcare provider before starting any new medication.

Mesalamine .375 g/1 capsules may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other gastrointestinal treatments. Alcohol and certain foods may also affect the efficacy of mesalamine. It is advisable to discuss all current medications and supplements with a healthcare provider to avoid potential interactions.